News

Biologic drugs for spondyloarthritis patients: do policies in different countries affect costs and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

Using information from DESIR, researchers looked at which patients satisfied the criteria to receive biologic drugs in different countries: France, Canada, Germany, the United Kingdom and Hong Kong.

Read More

Biologic drugs for SpA: does following recommendations affect patients’ cost and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

This study used information from DESIR to look at the effect of following doctors’ recommendations about who should use biologic drugs.

Read More

How can we tell if Ankylosing Spondylitis care is being given according to recommendations?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

The study discovered that specialist doctors have some differences of opinion about recommended AS care.

Read More

The cost of SpA: results from patients in the DESIR cohort

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

This study created a database of cost and health information that will let researchers look into many questions that affect SpA (short for spondyloarthritis) patients.

Read More

Unique Online Tool Gives RA Patients Confidence When Deciding Treatment

Unique Online Tool Gives RA Patients Confidence When Deciding Treatment   To...
Read More

 

LATEST NEWS

 

FULL-TIME RESEARCH ASSISTANT

Arthritis Research Canada is seeking a Full-time Research Assistant to assist with projects using administrative health databases and surveys to study arthritis.   Arthritis Research Canada (ARC) is an independent, not for profit charitable organization that is...

read more

Biologic drugs for spondyloarthritis patients: do policies in different countries affect costs and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

Using information from DESIR, researchers looked at which patients satisfied the criteria to receive biologic drugs in different countries: France, Canada, Germany, the United Kingdom and Hong Kong.

read more

Biologic drugs for SpA: does following recommendations affect patients’ cost and health?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

This study used information from DESIR to look at the effect of following doctors’ recommendations about who should use biologic drugs.

read more

How can we tell if Ankylosing Spondylitis care is being given according to recommendations?

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

The study discovered that specialist doctors have some differences of opinion about recommended AS care.

read more

The cost of SpA: results from patients in the DESIR cohort

Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health

This study created a database of cost and health information that will let researchers look into many questions that affect SpA (short for spondyloarthritis) patients.

read more

IMPROVING QUALITY OF CARE FOR RHEUMATOID ARTHRITIS

Co-Principal Investigators:

Claire Barber MD, PhD, Assistant Professor, Division of Rheumatology, Department of Medicine, University of Calgary, Research Scientist, Arthritis Research Canada

Diane Lacaille, MD, MHSc, FRCPC, Senior Research Scientist, Arthritis Research Canada, Professor, Division of Rheumatology, Faculty of Medicine, UBC, Acting Co-Head Academic Affairs, Department of Medicine, UBC, Mary Pack Chair in Arthritis Research (Rheumatology)

One approach to monitoring and improving the quality of care provided to patients is the implementation of a balanced scorecard. Like a report card, a balanced scorecard is a structured approach to improving efficiency and performance that represents viewpoints from multiple stakeholder perspectives.

read more

Will using your arthritis medications during pregnancy cause you or your baby to have more infections?

Mary De Vera, BSc, MSc, PhD, Research Scientist, Arthritis Research Canada; Assistant Professor, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver

The goal of this research is to find out whether using these medications during pregnancy causes moms and babies to have more infections, so that appropriate prevention and monitoring can take place to ensure that both moms and babies can be healthy.

read more